Malaria diagnostic capacity in health facilities in Ethiopia by unknown
Abreha et al. Malaria Journal 2014, 13:292
http://www.malariajournal.com/content/13/1/292RESEARCH Open AccessMalaria diagnostic capacity in health facilities in
Ethiopia
Tesfay Abreha1, Bereket Alemayehu2, Yehualashet Tadesse1, Sintayehu Gebresillassie1, Abebe Tadesse1,
Leykun Demeke1, Fanuel Zewde1, Meseret Habtamu1, Mekonnen Tadesse1, Damtew Yadeta3, Dawit Teshome3,
Addis Mekasha3, Kedir Gobena3, Henock Bogale4, Zenebe Melaku1, Richard Reithinger5,6 and Hiwot Teka6*Abstract
Background: Accurate early diagnosis and prompt treatment is one of the key strategies to control and prevent
malaria in Ethiopia where both Plasmodium falciparum and Plasmodium vivax are sympatric and require different
treatment regimens. Microscopy is the standard for malaria diagnosis at the health centres and hospitals whereas
rapid diagnostic tests are used at community-level health posts. The current study was designed to assess malaria
microscopy capacity of health facilities in Oromia Regional State and Dire Dawa Administrative City, Ethiopia.
Methods: A descriptive cross-sectional study was conducted from February to April 2011 in 122 health facilities,
where health professionals were interviewed using a pre-tested, standardized assessment tool and facilities’
laboratory practices were assessed by direct observation.
Results: Of the 122 assessed facilities, 104 (85%) were health centres and 18 (15%) were hospitals. Out of 94 health
facilities reportedly performing blood films, only 34 (36%) used both thin and thick smears for malaria diagnosis.
The quality of stained slides was graded in 66 health facilities as excellent, good and poor quality in 11(17%), 31
(47%) and 24 (36%) respectively. Quality assurance guidelines and malaria microscopy standard operating
procedures were found in only 13 (11%) facilities and 12 (10%) had involved in external quality assessment
activities, and 32 (26%) had supportive supervision within six months of the survey. Only seven (6%) facilities
reported at least one staff’s participation in malaria microscopy refresher training during the previous 12 months.
Although most facilities, 96 (79%), had binocular microscopes, only eight (7%) had the necessary reagents and
supplies to perform malaria microscopy. Treatment guidelines for malaria were available in only 38 (31%) of the
surveyed facilities. Febrile patients with negative malaria laboratory test results were managed with
artemether-lumefantrine or chloroquine in 51% (53/104) of assessed health facilities.
Conclusions: The current study indicated that most of the health facilities had basic infrastructure and equipment
to perform malaria laboratory diagnosis but with significant gaps in continuous laboratory supplies and reagents,
and lack of training and supportive supervision. Overcoming these gaps will be critical to ensure that malaria
laboratory diagnosis is of high-quality for better patient management.Background
Globally, an estimated of 3.4 billion people live in areas
at risk of malaria. In 2012 there were 207 million cases
of malaria and 627, 000 deaths; 90% of these deaths oc-
curred in sub-Saharan Africa [1]. Approximately 75% of
Ethiopia’s landmass is endemic for malaria transmission,
with 58 million people at risk of infection and disease* Correspondence: hiwtek@yahoo.com
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unless otherwise stated.[2]. Malaria is one of the top ten causes of morbidity,
accounting for 17% of all cases and 8% of health facility
admissions in 2012 [3].
Accurate early diagnosis and prompt treatment of mal-
aria is among the core strategies to prevent and control
malaria [4]. Despite significant funding for HIV/AIDS,
tuberculosis and malaria in the past decade (e. g. through
the Global Fund to Fight AIDS, Tuberculosis and Malaria;
the U.S. President’s Emergency Plan for AIDS Relief and
President’s Malaria Initiative), laboratory systems in devel-
oping countries remain weak. Major challenges includeLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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materials and reagents, limited human capacity, lack of
policies and strategic plans, and limited synergies between
clinical and laboratory services [5,6]. Strong laboratory
systems not only ensure that curative interventions are
more effective (e. g., by avoiding prescription of artemisi-
nin combination therapy (ACT) to patients with non-
malarial causes of fever), but also affect treatment-seeking
behaviour (i. e. health facilities with a strong laboratory
service tend to experience greater access by patients than
facilities with a weak laboratory service) [7].
Following the WHO recommendations of universal diag-
nostic testing for all suspected malaria cases [8], Ethiopia
scaled up diagnostic testing for malaria at all levels of the
public sector’s health service delivery system: multispecies
rapid diagnostic tests (RDTs) are used at community-level
health posts and malaria microscopy is carried out at
district-level health centres as well as district-, zonal- and
regional-level hospitals [9].
Microscopy requires a functional laboratory set-up
with quality diagnostic services and trained laboratory
personnel [5]. Published peer-reviewed literature on in-
country laboratory capacity, including for malaria, is
scarce. Existing data comes almost exclusively from grey
literature [10-13], showing low malaria microscopic diag-
nostic capacity that ranges from 25% in Uganda, to 33% in
Tanzania and 37% in Rwanda. In 2009, assessment of mal-
aria diagnosis capacity in 69 health facilities in Oromia
Regional State showed that although most facilities (i. e. 51
(88%)) did provide malaria microscopy services, they faced
a myriad of challenges, including limitations in trained
personnel, functional laboratory equipment and micro-
scopes, standard operating procedures (SOP) and guide-
line availability, and continuous supply of necessary
reagents and materials [14].
The objective of the survey presented here was to ex-
pand the assessment of malaria diagnostic capacity be-
yond the five administrative zones of Oromia covered in
2009 to facilities within all of Oromia’s 18 zones, as well
as Dire Dawa City Administration.
Methods
Study design and site selection
A descriptive cross-sectional study was conducted from
February to April 2011. A convenience sampling method
was used to select 126 health facilities, from 108 malaria-
endemic districts in 18 administrative zones of Oromia
National Regional State and Dire Dawa City Adminis-
tration. Oromia is the largest regional state in Ethiopia
covering 359,620 km2 (latitude 8°00’ N, longitude 39°
00’ E); the topography is diverse, with altitude ranging
from 500 m to 4,377 m above sea level (asl). The annual
mean temperature is 19°C (range: 10 - 30°C); annual rain-
fall ranges from 400 – 2,400 mm, with bi-modal rainyseasons. Dire Dawa is a chartered city located in the east-
ern part of Ethiopia (latitude 9° 36’ N, longitude 41° 52’ E).
It covers an area of 1213 km2; with altitude ranging from
960 m to 2,450 m asl. The annual mean temperature is
25°C (range: 18 - 31°C); average annual rainfall is 604 mm.
Between July 2012 and June 2013, an estimated 1,058,240
malaria cases were reported in Oromia and 661 cases in
Dire Dawa, accounting 23% and 0.01% of the country’s
malaria burden, respectively [15].
Data collection and analysis
Three assessment teams, composed of staff from the
Oromia Regional Health Bureau (ORHB), Oromia Re-
gional Reference Laboratory, zonal and district health of-
fices and Columbia University’s International Center for
AIDS Care and Treatment Programs (ICAP) in Ethiopia,
carried out the survey, collecting all data using a pre-
tested, structured data collection tool. The tool has a
questionnaire section that included: (i) general informa-
tion about the facilities, including access to water and
power supply; (ii) information on type of malaria labora-
tory services provided, including availability of human
resources, essential laboratory and clinical equipment
and supplies, quality assurance (QA) protocols for malaria
laboratory diagnostics, status of biosafety and implemen-
tation; and, (iii) information on laboratory-confirmed
malaria data at each health facility. In addition the tool in-
cluded check list for other observed variables. The survey
approach included interviews of health facility personnel,
review of secondary data of laboratory registers and direct
observation of services provided.
The collected data were checked for completeness and
consistency, and double entered into a SPSS17.0 (SPSS
Inc. Chicago, USA) database. Descriptive statistical ana-
lysis was done using STATA 11.0 (STATA Corp. Texas,
USA).
Ethical consideration
The survey was not reviewed by an ethical review commit-
tee. As it was part of the routine programme manage-
ment, permission for conducting the survey was obtained
from ORHB and Dire Dawa City Administration Health
Bureau. No patient information or identifiers were col-
lected in the survey; only data on facilities’ characteristics
were collected, with a summary report provided to rele-
vant authorities.
Results
Facility characteristics and infrastructure
Among the 126 selected facilities, no data were available
from four facilities due to the absence of a laboratory
unit or laboratory personnel at the time of the survey.
Of the 122 surveyed facilities, 104 were health centres
and 18 were hospitals (Figure 1). The median numbers
Figure 1 Location of surveyed facilities.
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(range: 28–200) in hospitals. All but one facility were
public sector facilities.
Although 97 (80%) facilities had access to electricity,
63 (65%) reported frequent power interruptions, with 55
(87%) reporting power interruptions at least once per
week; 49 (40%) facilities had back-up generators for elec-
tricity. Of the assessed laboratories, 86 (70%) had access
to water; 76 (88%) of these were using tap water as their
source, with the remainder using well or rain water.
Facilities reporting interruption of water and electric
power services affecting the diagnosis of malaria were 38
(31%) and 69 (57%), respectively.
Laboratory equipment and consumables
Of surveyed facilities, 119 (98%) had at least one func-
tional binocular microscope, 102 (84%) and 66 (54%)
had functional electric and manual centrifuges, respect-
ively. Slide staining racks were available in 30 (25%) fa-
cilities, and slide drying racks and staining troughs were
available in 29 (24%) and 21 (17%) facilities, respectively.
No facility had a functional pH meter. Other major andminor laboratory equipment are listed in Tables 1 and 2.
Only one facility reported to have laboratory staff trained
and designated to maintain equipment.
Problems in continuous supply of laboratory consum-
ables was reported from 55/117 (47%) surveyed facilities
for Giemsa stain solution, 36 (30%) for microscopic slides,
90/118 (76%) for lens tissue, 45/118 (38%) for immersion
oil, and 80/114 (70%) for lens cleaning solution (Table 3).
Malaria RDTs were available in 70 (57%) facilities.
In all the surveyed facilities the reagents were made
available through the respective district or zonal health
offices. Reagents were stored at room temperature with
the exception of one facility, where reagents were stored
in a refrigerator. Correctly labelled reagents were found
in 74 (61%) facilities, although only 19 (16%) showed a
clear record of expiry dates.
The minimum package of equipment and reagent re-
quired for malaria microscopy (i. e., microscope, slide,
staining vessel, lens cleaning tissue, measuring cylinder,
optical lens cleaner, immersion oil, Giemsa stain, metha-
nol, gloves, blood lancets, sanitary cotton and ethanol)
was available in eight (7%) of the health facilities.
















119 (98%) 53 (43%) 1 (0.8%)
Spare bulbs for
microscopes
35 (29%) No data 83 (68%)
Electric centrifuges 102 (84%) 26 (21%) 16 (13%)
Manual centrifuges 66 (54%) 16 (13%) 51 (42%)
Weighing scale 22 (18%) 3 (2%) 95 (78%)
Colorimeter 14 (11%) 3 (2%) 105 (86%)
Haemoglobinometer 66 (54%) 5 (4%) 51 (42%)
Micro HCT
centrifuge
44 (36%) 8 (6.5%) 73 (60%)
Refrigerator 66 (54%) 10 (8%) 50 (41%)
Autoclave 19 (16%) 2 (1.6%) 99 (81%)
Blood cell analyzer 15 (12%) 2 (1.6%) 100 (82%)
pH meter 0 (0%) 1 (0.8%) 115 (94%)














Giemsa stain 55 (47%) 56 (48%) 6 (5%)
Field stain 15 (15%) 4 (4%) 83 (81%)
Lancets 30 (26%) 77 (68%) 7 (6%)
Pasteur pipettes 60 (52%) 46 (40%) 9 (8%)
Sharps containers 37 (32%) 78 (68%) 0 (0%)
Microscope slides 36 (30%) 78 (64%) 0 (0%)
Immersion oil 45 (38%) 72 (62%) 0 (0%)
Lens tissue 90 (76%) 25 (21%) 3 (3%)
Lens cleaning
solution
80 (70%) 19 (17%) 15 (13%)
Biohazard
container
75 (66%) 39 (34%) 0 (0%)
Alcohol 43 (36%) 75 (64%) 0 (0%)
Bleach 42 (35.5%) 75 (63.5%) 1 (1%)
Gloves 56 (48%) 60 (51%) 1 (1%)
First aid kit 56 (62%) 8 (9%) 53 (45%)
Glycerol 58 (49%) 31 (26%) 29 (25%)
Methanol AR
grade
47 (40%) 55 (46.5%) 16 (13.5%)
Na2HPO4 buffer 65 (55%) 9 (8%) 44 (37%)
KH2OPO4 buffer 66 (56%) 7 (6%) 45 (38%)
pH paper 84 (71%) 7 (6%) 27 (23%)
Filter paper 86 (73%) 23 (20%) 8 (7%)
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Hospitals had a greater number of skilled professional
staff, probably due to serving a larger population: all
medical specialists 51 (100%) and 95 (92%) of general
practitioners reported in the 122 facilities worked in
hospitals. In total, 275 laboratory personnel were found
to work in the surveyed health facilities, with 120 (44%)
working in hospitals and 155 (56%) in health centres
(Table 4). The number of laboratory staff in each health
facilities ranged from one to 21 (health centres: one to
six; hospital: three to 21); the majority (i. e., 74%) ofTable 2 Minor laboratory equipment in the 122 facilities
surveyed





Slide staining racks 30 (25%) 88 (72%)
Slide drying racks 29 (24%) 88 (72%)
Automatic pipettes 46 (38%) 72 (59%)
Timers 94 (77%) 23 (19%)
Tally counters 21 (17%) 97 (76%)
Differential counters 82 (67%) 36 (30%)
Fridge thermometers 34 (28%) 84 (69%)
Staining troughs 21 (17%) 97 (80%)
Slide storage boxes 65 (53%) 53 (43%)
Beakers 43 (35%) 74 (61%)
Flasks 44 (36%) 72 (59%)surveyed facilities had two to three laboratory staff and
44 (36%) had only one.
The qualification of the laboratory personnel varied
from diploma level in medical laboratory science to those
with postgraduate studies. Of surveyed facilities with la-
boratory personnel, 89 (73%) had at least one laboratory
technician with diploma level undergraduate training, 80
(66%) had laboratory technologists with BSc degree levelTable 4 Distribution of clinical and laboratory health








51 (60%) 34 (40%)
General practitioners 95 (92%) 8 (8%)
Health officer 64 (33%) 131 (67%)
Nurse 737 (46%) 882 (54%)
Health assistant 12 (38%) 20 (62%)
Laboratory staff 120 (44%) 155 (56%)
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were found in five laboratories.
In seven (6%) of the surveyed facilities, at least one
staff reported having participated in malaria microscopy
refresher training within the previous year. Other re-
fresher training, such as training on RDTs was reported
in three (2%) facilities, and laboratory personnel trained
in supply chain management were found in eight (7%)
facilities.
Biosafety
During the survey, laboratory staff were observed to wear
protective gloves and coats in 83 (68%) and 91 (75%) of fa-
cilities, respectively. Among the surveyed facilities, hand
washing areas were observed in 65 (53%), and 27 (22%)
had properly labelled and collected biohazardous mate-
rials. Sharp boxes were used to dispose contaminated
sharps in 91 (75%) facilities, with remaining facilities using
biohazard bags and waste bins (Table 5).
Treatment guidelines, laboratory request and related
forms
Malaria treatment guidelines were available in 38 (31%)
of surveyed facilities. Laboratory request forms were avail-
able in 51 (42%) facilities and those without request forms
used plain paper; only 37 (30%) facilities had properly
completed request forms and seven (6%) facilities did not
use request forms despite their availability. Request forms
included the clinician’s clinical impressions in 13 (11%) of
the facilities assessed. Registers were found in 118 (97%)
facilities, the majority of them (i. e., 93/118 (79%)) keeping
neat and legible records. Other records, including records
for laboratory equipment maintenance, were available in
11 (9%) facilities.
Laboratory services for malaria
Although, theoretically, all facilities should provide mi-
croscopy services, only 94 (77%) facilities performed blood
films. In these facilities, a total of 220,341 blood films had
been performed within the year preceding the survey, i. e.,









People in laboratory wear
protective gloves
83 (68%) 12 (10%) 22 (18%)
People in laboratory wear
protective coats
91 (75%) 8 (7%) 16 (13%)
Hand washing facility in
laboratory
65 (53%) 4 (3%) 46 (38%)
Disinfectants/
decontaminants use
81 (66%) 3 (2%) 30 (25%)
Antiseptic use 86 (70%) 3 (2%) 24 (20%)were also observed and reported to be used in 38 (31%)
and 27 (22%) of the facilities, respectively. Of the surveyed
facilities, 34 (28%) prepared both thick and thin blood
films for malaria diagnosis; 57 (47%) prepared thick films
only and three (2%) prepared thin films only. Malaria
species identification was performed in 78 (64%) facil-
ities; three (2%) facilities reported or were observed to
perform parasite counts. Haemoglobin estimation was
done in 78 (64%) facilities, out of which 31 (40%) used
the haematocrit technique, 29 (37%) used colorimetry,
and the remaining 18 (23%) facilities used an automated
analyzer.
Quality assurance
Guidelines and standard operating procedures (SOPs)
Out of the 122 facilities surveyed, 13 (11%) facilities re-
ported to have the National Malaria Laboratory Diagnosis
External Quality Assessment (EQA) Scheme Guideline
[16]; two health facilities were observed using the protocol
recommended in the guidelines; a QA protocol for mal-
aria RDTs was available in nine (7%) facilities. SOPs for
malaria microscopy and RDT were available in 12 (10%)
and five (4%) facilities, respectively; job aids for micros-
copy were available in 30 (25%) facilities. Bench aids for
malaria microscopy were available in 16 (13%) and dis-
played in 11 (69%) of these facilities; four facilities (3%)
had displayed bench aids for RDTs.
Internal quality control and EQA
Among the 122 surveyed facilities, six (5%) facilities re-
ported to have an internal quality control (QC) process,
where slides were re-read by assigned staff within the la-
boratory; however, only one facility kept a record of in-
ternal QC data and two (2%) facilities were observed to
archive malaria slides for EQA purposes.
Among the facilities surveyed 12 (10%) reported to be
involved in EQA: three (2%) and nine (7.4%) facilities re-
ported that external re-reading of slides was performed
two to four times and once per year, respectively. The
quality of smearing and staining of the malaria slides
prepared in the assessed laboratories was observed and
rated for 66 facilities: slides from only 11 (17%) facilities
were found to be of excellent quality, with the remainder
being of either good (31 (47%)) or poor (24 (36%))
quality (Table 6).
Supportive supervision
Supportive supervision had been provided within six
months prior to the survey in 32 (26%) facilities. External
bodies that provided the supervision included the Ministry
of Health, the Ethiopian Public Health Institute (EPHI),
ORHB, zonal health departments, and non-governmental
organizations (NGOs).
Table 6 Criteria for assessing quality of malaria blood film slide according to national malaria laboratory diagnosis
external quality assessment scheme guideline
Grade Criteria for assessing the quality of malaria blood film smearing and staining characteristics # facilities
Excellent Gross appearance: Both thin and thick film prepared on the same slide, thick film 10 mm diameter, newsprint read
under thick film before staining, 10 mm from frosted end and thick film and between thick and a thin film with
distinct head, body and tail.
11
Microscopic appearance: Demonstrates RBCs lysed in thick film and a monolayer of RBCs, with normal and
abnormal morphology in thin film. Staining allows the trophozoites, gametocytes and/or schizonts and the white
blood cells to be clearly distinguished against the background.
Good Gross appearance: Film with uneven tail, too thick, too wide or too long with uneven thickness. 31
Microscopic appearance: Demonstrates a monolayer of RBCs, and fixed RBCs. Staining allows the trophozoits,
gametocytes and/or schizonts malaria parasites and the white blood cells to be clearly distinguished against
the background.
Poor Gross appearance: Film with ragged tail, too thick, too wide or too long with uneven thickness. 24
Microscopic appearance: Distorted appearance of the RBCs, malaria parasite and the white cells. Difficult to spot
fields with monolayer of cells and distorted appearance of the RBCs, malaria parasite and the white cells.
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A test for malaria (microscopy or RDTs) was requested
based on symptoms of patients in all the facilities sur-
veyed. Clinical staff evaluating patients discussed the test
results with laboratory personnel in 79 (65%) facilities.
When clinicians disagreed with the laboratory test re-
sults, they independently made their own treatment de-
cisions or discussed with the laboratory personnel the
subsequent steps for diagnosis and patient management.
Clinical personnel from 53 (51%) of the surveyed health
facilities responded that they sometimes clinically treated
patients with anti-malarial drugs while ignoring the la-
boratory test results, 28 (27%) responded that they order
a repeat blood film to be made, and 16 (15%) responded
that they further assess patients for other acute febrile
illnesses. Very few clinicians responded that they used a
combination of options, including clinical treatment
and ordering RDT-testing (four (4%)), both clinical
treatment and ordering a repeat blood film (two (2%)),
or having the patient re-tested by microscopy as well as
RDT (one (1%)).
Discussion
Strong national health laboratory capacity is crucial to
prevent, manage and ultimately control diseases such as
malaria. In Ethiopia, 4,782,064 (47%) of the 10,088,744
total cases of suspected malaria were diagnosed using
microscopy at the health centres or hospitals in 2012
[15]. The findings of the survey reported here confirm
major findings from a previous, smaller assessment estab-
lishing a laboratory capacity-strengthening programme in
Oromia. Although malaria laboratory diagnostic services
were available in all facilities surveyed, significant gaps
were observed in laboratory infrastructure, equipment,
materials and reagent supply chains, human resource
capacity, availability of policies, strategic plans and op-
erational procedures, and laboratory services and datarecording. This limitation clearly could be one of the
main explanations as to why proportion of suspected
malaria cases in Ethiopia remain unconfirmed and are
treated presumptively.
Availability of water and electricity in assessed laborator-
ies was high (>70%), but laboratory services were report-
edly undermined by the frequent interruption of power
and water, particularly if a back-up solution (e g, electric
generators) was not available. Similarly to the assessment
in 2009, a number of laboratories was observed to have
gaps in equipment, materials and reagents (Tables 1, 2 nd
3), and some facilities were not able to provide certain ser-
vices at all or, in the case of shortages, during certain times
of the year. Thus, even though the national policy [3]
states that microscopy should be used at health centre
and hospital levels, more than half of surveyed facilities
used RDTs, partially because functional microscopes
were not available.
All laboratory personnel had at least diploma level
training (i. e., two years). Pre-service training tends to
focus on the technical theory of general laboratory skills
(e. g., types of diagnostic tests, including haematology,
chemistry) rather than developing practical malaria la-
boratory diagnosis skills (e. g., slide reading, species identi-
fication and parasite counting). While in-service training
tends to be more practical, there is limited opportunity for
in-service training; only a few facilities, had at least one
staff participating in malaria microscopy refresher training
during the previous year, quarter of the staff were pro-
vided with supportive supervision, and 12 (10%) were in-
cluded in an EQA that involved external re-reading of
slides. Although in-service training cannot replace com-
prehensive pre-service training, a well-thought-out, in-
service training curriculum can significantly improve
blood slide preparation and accuracy of microscopy [17].
Laboratory test requests are made for suspected malaria
cases in all of the 122 health facilities, but against national
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nificant number of health facilities for suspected patients
testing negative. Similar behaviour has been reported in
numerous other malaria-endemic countries, including
Tanzania and Zambia [18-21], which clearly undermines
malaria prevention, case management and control efforts,
as well as being medical malpractice (e. g., delaying treat-
ment of infections of non-malarial aetiology could poten-
tially result in deaths). Importantly, several studies have
shown that withholding anti-malarial treatment of RDT-
negative patients does not result in increased morbidity
and mortality [22,23]. Generally, the findings indicate that
clinicians do not rely on laboratory test results, because of
malfunctioning and poorly maintained equipment [24],
limited training of laboratory personnel, poor laboratory
QA [19], lack of competency in clinical training or prac-
tice for malaria case management as shown here and else-
where [25,26].
Only a few health facilities had SOPs, guidelines, bench
and job aids for reference purposes. Coupled with the
abovementioned challenges in infrastructure, equipment,
reagents, supervision, and training, it was not surprising
that a large proportion of health facilities were ranked as
either good or poor when evaluated through the quality of
prepared malaria microscopy slides.
Going forward, the malaria laboratory diagnosis and
QA programme will focus on addressing needs and gaps
identified that can be easily addressed, including supply
of equipment (e. g., microscopes), reagents and materials
(e. g., gloves, stains, slides), human resource capacity (e. g.,
through in-service training of laboratory and clinical
staff, and supportive supervision), and availability of
guidelines and job aids. Additionally, collaboration with
EPHI and ORHB to implement an EQA scheme, which
is currently being rolled out across Ethiopia, and avail-
ability and use of the updated National Malaria Case
Management Guidelines at all levels in the health system
will be strengthened [4]. Other needs and gaps, including
rehabilitation of facilities, provision of continuous water
and electricity, and provision of laboratory personnel will
need additional financial investment. Together with the
continued roll-out of multispecies RDTs at community
level, it is hoped that increasing the laboratory capacity of
health facilities through QA programmes [27] will ensure
that fever cases in Ethiopia are increasingly accurately
diagnosed. This should increase health service delivery
overall, access of facilities by patients, as well as de-
crease the total cost of diagnosis and treatment (poten-
tially by up to 46%) [28].
It could be considered that a possible caveat of the
study is its design, i.e. a purposefully sampled number of
facilities. However, given the number of facilities sur-
veyed over an extensive geographic area, the findings’
likeness to a smaller, earlier study, as well as the studyteam’s knowledge of the context and infrastructure, the
authors do not believe that the study’s outcome would
have been different if another random selection of facil-
ities would have been surveyed. Moreover, while they ac-
knowledge that respondent bias may be questioned, the
tool included a checklist that directed the study team to
directly observe much of the facilities’ infrastructure,
services and practices.
Conclusions
The large investment in HIV/AIDS, tuberculosis and mal-
aria has resulted in a dramatic scale-up of disease preven-
tion (e g, long-lasting insecticide-treated nets for malaria)
and curative services to remote populations. Unfortu-
nately, laboratory capacity and services have not always
kept pace with this expansion. The current standardized
assessment provided a snapshot of laboratory capacity
across sampled facilities in Ethiopia, showing significant
gaps in supplies and equipment, as well as quality assur-
ance and supportive supervision for malaria diagnosis.
While baselines such as these are important in order to
monitor and evaluate the impact of operational laboratory
strengthening programming over time, they also show the
multi-faceted challenges that such programming need to
address in order to ensure that patients are correctly diag-
nosed and ultimately treated.
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